CT
CELG

Cambridge Trust’s Celgene Corp CELG Stock Holding History

Cambridge Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,365
Closed -$479K – 253
2018
Q1 		$479K Sell
5,365
-20,028
-79% -$1.92M 0.03% 182
2017
Q4 		$2.65M Sell
25,393
-87,222
-77% -$9.84M 0.17% 94
2017
Q3 		$16.4M Sell
112,615
-193
-0.2% -$26.3K 1.1% 35
2017
Q2 		$14.7M Sell
112,808
-8,307
-7% -$1.02M 1.01% 37
2017
Q1 		$15.1M Buy
121,115
+1,465
+1% +$175K 1% 36
2016
Q4 		$13.8M Buy
119,650
+62,528
+109% +$6.96M 0.98% 39
2016
Q3 		$5.97M Buy
57,122
+16,948
+42% +$1.83M 0.44% 67
2016
Q2 		$3.96M Buy
+40,174
New +$4.16M 0.3% 78

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Trust's CELG Position: Q2 2018 in Review

Cambridge Trust sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 5,365 shares — an estimated $479K sold.

Cambridge Trust first reported a position in CELG in Q2 2016 and held it in 8 quarters. The position peaked at $16.4M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Cambridge Trust reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Cambridge Trust sold 5,365 Celgene Corp shares in Q2 2018, an estimated $479K.
  • Cambridge Trust first reported a position in Celgene Corp in Q2 2016 and held it in 8 quarters.
  • Cambridge Trust's Celgene Corp position peaked at $16.4M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Cambridge Trust's 13F filing for Q2 2018, filed 6 Aug 2018.